BioNTech SE (BNTX) — Technical state

As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

Signal: Death cross — Its 50-day crossed below its 200-day 6 sessions ago — a death cross, the classic trend-turn-lower. (as of 2026-11-09)
Trend: BioNTech SE trades 7.3% below its 50-day and 9.2% below its 200-day moving average. (as of 2026-11-09)
Index seat: Euro-AI 50

BioNTech develops immunotherapies, best known for its mRNA-based vaccine against SARS-CoV-2. It also runs a broad oncology pipeline spanning lung, breast, colorectal and other solid tumours, alongside infectious-disease candidates for influenza, tuberculosis and malaria.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the BNTX overview. Research diary readings, not advice.

Death cross

Its 50-day crossed below its 200-day 6 sessions ago — a death cross, the classic trend-turn-lower.

The moving-average stack

vs 20-day-1.1%
vs 50-day-7.3%
vs 200-day-9.2%
52-week band29.4% off the high · +10% off the low
CrossoverDeath cross 6 sessions ago
Stochastic%K 26 · %D 34 · down cross

Continue: the BNTX chart & overview · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-09

Quick answers

What is the current Closelooknet signal on BNTX?

Death cross — Its 50-day crossed below its 200-day 6 sessions ago — a death cross, the classic trend-turn-lower. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is BNTX above its 50-day and 200-day moving averages?

As of 2026-11-09, BioNTech SE trades -7.3% below its 50-day and -9.2% below its 200-day average, with the 20-day -1.1% away.

How far is BNTX from its 52-week high?

29.4% below the 52-week high and 10% above the 52-week low, as of 2026-11-09.

Related in the Closelooknet universe

same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.